These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38886824)

  • 1. 'I take the drugs… to make the sickness to move out of me': key populations' and service provider perspectives about facilitators and barriers to ART adherence and retention in care in Nigeria.
    Dirisu O; Eluwa GIE; Callens S; Adams E; Akinwunmi A; Geibel S; Iyortim I
    Arch Public Health; 2024 Jun; 82(1):88. PubMed ID: 38886824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multilevel determinants of antiretroviral therapy initiation and retention in the test-and-treat era of Nepal: a qualitative study.
    Shrestha A; Poudel L; Shrestha S; Jha N; Kuikel BS; Shakya P; Kunwar RS; Pandey LR; Kc MB; Wilson EC; Deuba K
    BMC Health Serv Res; 2024 Aug; 24(1):927. PubMed ID: 39138448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Facilitators and barriers to uptake and adherence to lifelong antiretroviral therapy among HIV infected pregnant women in Uganda: a qualitative study.
    Buregyeya E; Naigino R; Mukose A; Makumbi F; Esiru G; Arinaitwe J; Musinguzi J; Wanyenze RK
    BMC Pregnancy Childbirth; 2017 Mar; 17(1):94. PubMed ID: 28320347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiretroviral therapy initiation and adherence in rural South Africa: community health workers' perspectives on barriers and facilitators.
    Loeliger KB; Niccolai LM; Mtungwa LN; Moll A; Shenoi SV
    AIDS Care; 2016 Aug; 28(8):982-93. PubMed ID: 27043077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Barriers and facilitators of male engagement in Community Client-Led Antiretroviral therapy Delivery groups (CCLADS) for HIV care and treatment in Southwestern Uganda: a qualitative study.
    Kushemererwa J; Muwanguzi M; Atukunda EC; Kikomeko HN; Ambrose O; Androdri D; Kembabazi B; Najjuma JN
    BMC Health Serv Res; 2022 Jan; 22(1):125. PubMed ID: 35093057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors influencing adherence to antiretroviral therapy from the experience of people living with HIV and their healthcare providers in Sierra Leone: a qualitative study.
    Lahai M; Theobald S; Wurie HR; Lakoh S; Erah PO; Samai M; Raven J
    BMC Health Serv Res; 2022 Nov; 22(1):1327. PubMed ID: 36348488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Barriers and facilitators of adherence to antiretroviral drug therapy and retention in care among adult HIV-positive patients: a qualitative study from Ethiopia.
    Bezabhe WM; Chalmers L; Bereznicki LR; Peterson GM; Bimirew MA; Kassie DM
    PLoS One; 2014; 9(5):e97353. PubMed ID: 24828585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 'I fear my partner will abandon me': the intersection of late initiation of antenatal care in pregnancy and poor ART adherence among women living with HIV in South Africa and Uganda.
    Alhassan Y; Twimukye A; Malaba T; Myer L; Waitt C; Lamorde M; Colbers A; Reynolds H; Khoo S; Taegtmeyer M
    BMC Pregnancy Childbirth; 2022 Jul; 22(1):566. PubMed ID: 35840939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health Provider Views on Improving Antiretroviral Therapy Adherence Among Men Who Have Sex with Men in Coastal Kenya.
    Micheni M; Kombo BK; Secor A; Simoni JM; Operario D; van der Elst EM; Mugo P; Kanungi J; Sanders EJ; Graham SM
    AIDS Patient Care STDS; 2017 Mar; 31(3):113-121. PubMed ID: 28282249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "Swallowing these drugs every day, you get tired": a mixed-methods study to identify Barriers and facilitators to retention and HIV Viral Load suppression among the Adolescents living with HIV in TASO Mbale and TASO Soroti centers of excellence.
    Oryokot B; Kazibwe A; Oluka AI; Kagimu D; Bakashaba B; Ssentongo S; Mafabi T; Odoi C; Kawuba A; Miya Y; Etukoit BM; Mugisha K; Namusoke-Magongo E
    Res Sq; 2024 Jan; ():. PubMed ID: 38313290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Provider perspectives on antiretroviral therapy adherence among psychiatric inpatients in Botswana.
    Qambayot MA; Naidoo S
    Afr J AIDS Res; 2023 Jul; 22(2):123-130. PubMed ID: 37337820
    [No Abstract]   [Full Text] [Related]  

  • 12. Barriers and Facilitators to HIV Treatment Adherence in Indonesia: Perspectives of People Living with HIV and HIV Service Providers.
    Hutahaean BSH; Stutterheim SE; Jonas KJ
    Trop Med Infect Dis; 2023 Feb; 8(3):. PubMed ID: 36977140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Barriers and facilitators to ART adherence among ART non-adherence people living with HIV in Cameroon: A qualitative phenomenological study.
    Buh A; Deonandan R; Gomes J; Krentel A; Oladimeji O; Yaya S
    PLoS One; 2023; 18(9):e0291487. PubMed ID: 37699048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Barriers and facilitators to antiretroviral adherence and retention in HIV care among people living with HIV in the Comarca Ngäbe-Buglé, Panama.
    Gabster A; Socha E; Pascale JM; Cabezas Talavero G; Castrellón A; Quiel Y; Gantes C; Mayaud P
    PLoS One; 2022; 17(6):e0270044. PubMed ID: 35709223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherence to antiretroviral therapy and retention in care for adolescents living with HIV from 10 districts in Uganda.
    Nabukeera-Barungi N; Elyanu P; Asire B; Katureebe C; Lukabwe I; Namusoke E; Musinguzi J; Atuyambe L; Tumwesigye N
    BMC Infect Dis; 2015 Nov; 15():520. PubMed ID: 26573923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Realities and challenges of breastfeeding policy in the context of HIV: a qualitative study on community perspectives on facilitators and barriers related to breastfeeding among HIV positive mothers in Baringo County, Kenya.
    Samburu BM; Kimiywe J; Young SL; Wekesah FM; Wanjohi MN; Muriuki P; Madise NJ; Griffiths PL; Kimani-Murage EW
    Int Breastfeed J; 2021 May; 16(1):39. PubMed ID: 33964950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Barriers to and facilitators of antiretroviral therapy adherence in Nepal: a qualitative study.
    Wasti SP; Simkhada P; Randall J; Freeman JV; van Teijlingen E
    J Health Popul Nutr; 2012 Dec; 30(4):410-9. PubMed ID: 23304907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Client and Provider Perspectives on Antiretroviral Treatment Uptake and Adherence Among People Who Inject Drugs in Indonesia, Ukraine and Vietnam: HPTN 074.
    Go VF; Hershow RB; Kiriazova T; Sarasvita R; Bui Q; Latkin CA; Rose S; Hamilton E; Lancaster KE; Metzger D; Hoffman IF; Miller WC
    AIDS Behav; 2019 Apr; 23(4):1084-1093. PubMed ID: 30306437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Test but not treat: Community members' experiences with barriers and facilitators to universal antiretroviral therapy uptake in rural KwaZulu-Natal, South Africa.
    Iwuji C; Chimukuche RS; Zuma T; Plazy M; Larmarange J; Orne-Gliemann J; Siedner M; Shahmanesh M; Seeley J
    PLoS One; 2020; 15(9):e0239513. PubMed ID: 32970730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mapping patient-identified barriers and facilitators to retention in HIV care and antiretroviral therapy adherence to Andersen's Behavioral Model.
    Holtzman CW; Shea JA; Glanz K; Jacobs LM; Gross R; Hines J; Mounzer K; Samuel R; Metlay JP; Yehia BR
    AIDS Care; 2015; 27(7):817-28. PubMed ID: 25671515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.